International Prostate Cancer Update Agenda 2019

Wednesday | January 23, 2019

11:00am-6:00pm

3rd International Bladder Cancer Update

Michael S. Cookson, MD, MMHC (Co-Chair)

Daniel P. Petrylak, MD (Co-Chair)

6:30pm-8:00pm

IBCU/IPCU/LUGPA Welcome Reception – Upstairs Library

Thursday | January 24, 2019

7:00am-7:10 am IPCU Welcome and Opening Remarks
E. David Crawford, MD – Program Director
7:10am-7:20am The Present and Future of LUGPA
Richard G. Harris, MD, President, LUGPA
7:20am-10:30am

SESSION I: PREVENTION, SCREENING, AND BIOMARKERS

Moderator: A. Karim Kader, MD, PhD

7:20am – 7:30am PSA 1.5 Is the New 4.0
E. David Crawford, MD
7:30am – 7:40am How to Optimize the Use of Prostate-specific Antigen in the Current Era
Sigrid V. Carlsson, MD, PhD, MPH
7:40am – 7:50am Panel Discussion/Questions and Answers
7:50am – 8:30am Educational Breakfast Symposium
Biomarkers for Early- and Late-stage Prostate Cancer Patients
Speaker: David M. Albala, MD
Supported by Genomic Health
8:30am – 8:50am Panel on Pros and Cons of the AUA, NCCN, and EAU Screening Guidelines
Moderator: Michael S. Cookson, MD, MMHC
Panelists: Sigrid V. Carlsson, MD, PhD, MPH, Neal D. Shore, MD, and A. Karim Kader, MD, PhD
8:50am – 9:10am
Break and Visit Exhibits- Riverside Foyer
9:10am – 9:20am 2019 Economic Outlook for Urology in the United States
Deepak A. Kapoor MD
9:20am – 9:30am 29 MHz High Resolution Micro-Ultrasound: Improving Real-Time Targeting of Prostate Biopsies
Neal D. Shore, MD  
9:30am – 9:40am Using High Resolution Micro-Ultrasound for Prostate Biopsies
Laurence Klotz, MD
9:40am – 9:50am New Applications and Clinical Possibilities in Prostate Cancer with Micro-Ultrasound
E. David Crawford, MD
9:50am – 10:00am Discussion/Question and Answers
10:00am – 10:10am Urinary Micro RNAs and SNOs as a Prostate Cancer Biomarker Platform
Laurence Klotz, MD
10:10am – 10:20am

Live-Primary Cell Phenotypic Biomarkers and Prostate Cancer Prognosis

David M. Albala, MD

10:20am – 10:30am Panel Discussion/Question and Answers
10:30am – 10:40am Prostate Cancer Screening: The Latin American Perspective
Arturo Mendoza-Valdes, MD
10:40am-10:50am Prostate Cancer Active Surveillance in 2019
Sigrid V. Carlsson, MD, PhD, MPH
10:50am – 11:00am Panel Discussion/Question and Answers
11:00am Adjourn
11:00am – 3:30pm Poster Sessions – Open Viewing
Gondola Ballroom
3:30pm – 4:00pm Refreshments and Visit Exhibits – Riverside Foyer
4:00pm – 5:30pm

SESSION II: LUGPA LECTURE SERIES

Moderator: Deepak A. Kapoor, MD

4:00pm – 4:30pm Panel Discussion on Integrating Cooperation Between LUGPA and Academic Medical Centers
Moderated by
Deepak A. Kapoor, MD
Panelists:
E. David Crawford, MD, Leonard G. Gomella, MD, Richard G. Harris, MD, Neal D. Shore, MD, R. Jonathan Henderson, MD, and Michael S. Cookson, MD MMHC
4:30pm – 4:40pm The AUA, CPT, and RUC: Interactions and Impact
Ronald P. Kaufman, Jr., MD, FACS
4:40pm –5:00pm Physician Burnout – What Can We Do To Prevent It?
Gerald L. Andriole, Jr., MD
5:00pm – 5:10pm Panel Discussion/Question and Answers
5:10pm – 5:30pm Panel Discussion on Women in Urology
Moderated by Wendy L. Poage, MHA
Panelists: Sigrid Carlsson, MD, PhD, MPH and Faina Shtern, MD
5:30pm – 5:45pm Break and Visit Exhibits – Riverside Foyer
5:45pm – 7:30pm

SESSION III: LOCALIZED DISEASE: ALTERNATIVE TECHNOLOGIES – PART 1

Moderator: Peter A. Pinto, MD

5:45pm – 5:55pm Brachytherapy/Caesium
Thomas J. Pugh, MD
5:55pm – 6:05pm 3DBiopsy™: Transperineal Mapping Biopsy
Nelson N. Stone, MD
6:05pm – 6:15pm Panel Discussion/Question and Answers
6:15pm – 6:25pm Salvage Lymph Node Dissection for Prostate Cancer
Paul D. Maroni, MD
6:25pm – 6:35pm TRUS Biopsy, MRI, and PROMIS Trial
Priya N. Werahera, PhD
6:35pm – 6:45pm Panel Discussion/Question and Answers
6:45pm – 6:55pm Second Opinion Diagnosis in Prostate Pathology
Francisco G. La Rosa, MD
6:55pm – 7:05pm Emerging Indications for a Novel Absorbable Hydrogel Spacer
Lawrence I. Karsh, MD, FACS
7:05pm – 7:15pm Focal Therapy for Localized Prostate Cancer: is There a “Middle Ground” Between Active Surveillance and Definitive Treatment?
John W. Davis, MD
7:15pm – 7:25pm Can MRI Be Used to Select Patients for Focal Therapy or To Guide Therapy?
Robert E. Reiter, MD
7:25pm – 7:35pm Panel Discussion/Question and Answers
7:35pm Adjourn and Evening On Own

Friday | January 25, 2019

7:00am – 9:00am

SESSION IV: LOCALIZED DISEASE: ALTERNATIVE TECHNOLOGIES – PART 2

Moderator: Gerald L. Andriole, Jr., MD

7:00am – 7:10am mpMRI, PI-RADS, and Multi-Modality Image Fusion for Targeted Definition and Tissue Sampling
Jelle Barentsz, MD, PhD
7:10am – 7:20am Limitations of MRI
Peter A. Pinto, MD
7:20am – 7:30am Panel Discussion/Question and Answers
7:30am – 8:30am Educational Breakfast Symposium
Elevate Care in Advanced Prostate Cancer
Speaker: Neal D. Shore
Supported by Astellas Pharma US and Pfizer Oncology
8:30am – 8:40am Fluciclovine (18F) PET/CT Impact on Clinical Management of Recurrent Prostate Cancer
Gerald L. Andriole, Jr., MD
8:40am – 8:50am A Review of the Third Global Summit on Precision Diagnosis and Treatment of Prostate Cancer
Faina Shtern, MD
8:50am – 9:00am Panel Discussion/Question and Answers
9:00am – 9:20am Break and Visit Exhibits – Riverside Foyer
9:20am – 10:30am

SESSION V: TOOLS FOR BUILDING A BETTER UROLOGY PRACTICE

Moderator: Richard G. Harris, MD

9:20am – 9:30am Tele-Health in Urology
Evan R. Goldfischer, MD, MBA
9:30am – 9:40am Future Options for Urology Practice Ownership
Gary M. Kirsh, MD
9:40am – 9:50am Panel Discussion/Question and Answers
9:50am – 10:00am What Makes Millennials Tick? Understanding the Young Urologist
Jason N. Hafron, MD
10:00am – 10:30am Panels on Careers in Academic Medicine vs. Careers in Independent and/or Group Practice
Moderator:
R. Jonathan Henderson, MD
Panel 1: Academic
Panelists: Gerald L. Andriole, Jr., MD, E. David Crawford, MD, Steven E. Finkelstein, MD, Leonard G. Gomella, MD, and Thomas E. Keane, MD
Panel 2: Independent Practice Panelists: Richard G. Harris, MD, Deepak A. Kapoor, MD, Gary M. Kirsh, MD, and Neal D. Shore, MD
10:30am Adjourn
10:45am – 12:45pm

Novel Technology Workshops on Micro-Ultrasound and Cryotherapy
Riverside Ballroom

3:30pm – 4:00pm Coffee Break and Visit Exhibits – Riverside Foyer
4:00pm – 5:30pm

SESSION VI:  MEN’S HEALTH

Moderator: Mark A. Moyad, MD, MPH

4:00pm – 4:15pm The Men’s Eating and Living (MEAL) Study: Men Changed Diet But Not Prostate Cancer Progression
J. Kellogg Parsons, MD, MHS, FACS
4:15pm – 4:30pm B______, Statins, Aspirin, and Metformin (B.S.A.M.): The Best Natural Pill for Patients Concerned About Prostate Cancer
Mark A. Moyad, MD, MPH
4:30pm – 4:45pm Recovering Sexual Function After Prostate Cancer
Mohit Khera, MD, MBA, MPH
4:45pm – 4:55pm Panel Discussion/Question and Answers
4:55pm – 5:40pm Choosing the StrongPath™: Reversing the Downward Spiral of Aging
Fred H. Bartlit, Jr., JD
6:00pm – 7:00pm

Moderated Poster Sessions | Gondola Ballroom
Moderator: L. Michael Glode, MD

7:00pm- 7:30pm Cocktail Reception – Gondola Ballroom Foyer
7:30pm- 9:00pm 4th Annual Fred Bartlit, Jr. Dinner – Gondola Ballroom
Keynote Speaker: Congressman Neal Dunn, MD (R – Florida)

Saturday | January 26, 2019

7:45am – 8:30am Androgen Targeted Therapy Across the Continuum of  PCa
Scott B. Sellinger, MD
Supported by TOLMAR Pharmaceuticals
8:30am – 9:30am

Educational Breakfast Symposium

ERLEADA® (apalutamide) For the Treatment of Patients With Non-Metastatic Castration-Resistant Prostate Cancer
Speakers: Lawrence I. Karsh, MD, FACS and Steven E. Finkelstein, MD
Supported by Janssen Biotech

9:30am – 9:50am Break and Visit Exhibits – Riverside Foyer
9:50am – 11:00am

SESSION VII: ADVANCED DISEASE

Moderator: Thomas E. Keane, MD

9:50am – 10:00am Timing of ADT with Chemotherapy
Thomas E. Keane, MD
10:00am – 10:20am

Point-Counterpoint: The Optimal Nadir T Level on ADT Is <20mg/mL

Pro:  E. David Crawford, MD
Con: John W. Davis, MD

10:20am – 10:30am Panel Discussion/Question and Answers
10:30am – 10:40am AR Resistance Mechanisms: Focusing on Variants and Testing
Raoul S. Concepcion, MD
10:40am – 10:50am New Considerations for Oligometastatic Prostate Cancer
Raoul S. Concepcion, MD
10:50am – 11:00am Panel Discussion/Question and Answers
11:00am Adjourn
3:30pm – 4:00pm Coffee Break and Visit Exhibits – Riverside Foyer
4:00pm – 5:45pm

SESSION VIII: ADVANCED AND METASTATIC PROSTATE CANCER

Moderator: Daniel P. Petrylak, MD

4:00pm – 4:10pm Navigating the M0 Space – Results of RADAR III
Neal D. Shore, MD
4:10pm – 4:20pm Bone Metastases and Mortality: Can We Be Doing More?
Leonard G. Gomella, MD
4:20pm – 4:30pm Panel Discussion/Question and Answers
4:30pm – 4:40pm Immunotherapy for PCa: Where Do We Go From Here?
Daniel P. Petrylak, MD
4:40pm – 4:50pm PARP in Combination with Standard-of-care Treatment
Daniel P. Petrylak, MD
4:50pm – 5:00pm Panel Discussion/Question and Answers
5:00pm – 5:10pm Update on Clinical Trials of Radium-223
Phillip J. Koo, MD
5:10pm – 5:20pm Therapeutic Radiopharmaceuticals and the Emergence of Theranostics
Phillip J. Koo, MD
5:20pm – 5:30pm Panel Discussion/Question and Answers
5:30pm – 5:45pm Next Generation Learning: The Key Take Home Messages from IPCU 29
E. David Crawford, MD
5:45pm Adjourn